Good day, and welcome to the Torchmark Corporation First Quarter 2018 Earnings Release Conference. Today's conference is being recorded. For opening remarks and introduction, I would now like to turn the conference over to Mr. Mike Majors, VP Investor Relations. Sir, please go ahead.

Thank you. Good morning, everyone. Joining the call today are Gary Coleman and Larry Hutchison, our Co-Chief Executive Officers; Frank Svoboda, our Chief Financial Officer; and Brian Mitchell, our General Counsel. Some of our comments or answers to your questions may contain forward-looking statements that are provided for general guidance purposes only. Accordingly, please refer to our 2017 10-K on file with the SEC. Some of our comments may also contain non-GAAP measures. Please see our earnings release and website for discussion of these terms, and reconciliations to GAAP measures. I'll now turn the call over to Gary Coleman.

Thank you, Mike, and good morning, everyone. In the first quarter, net income was $174 million or $1.49 per share, compared to $134 million or $1.11 per share a year ago. Net operating income for the quarter was $172 million or $1.47 per share or per share increase of 28% from a year ago. Without the impact of tax reform, we estimate that the growth would have been approximately 9%. On a GAAP reported basis, return on equity as of March 31 was 11.5% and book value per share was $50.13. Excluding unrealized gains and losses on fixed maturities, return on equity was 14.6% and book value per share grew 25% from a year ago to $40.94. In our life insurance operations, premium revenue increased 4% to $598 million and life underwriting margin was $155 million, up 7% from a year ago. Growth in underwriting margin exceeded premium growth, due to higher margins at American Income and Direct Response. For the year, we expect life underwriting income to grow around 4% to 5%. On the health side, premium revenue grew 3% to $252 million, and health underwriting margin was up 9% to $58 million. Growth in underwriting margin exceeded premium growth due to higher margins at Family Heritage and American Income. For the year, we expect health underwriting income to grow around 4% to 5%. Administrative expenses were $55 million, up 7% from a year ago and in line with our expectations. As a percentage of premium, administrative expenses were 6.5% compared to 6.3% a year ago. For the year, we expect administrative expenses to be around 6.4% of premium. I will now turn the call over Larry for his comments on the marketing operations.

Thank you, Gary. At American Income, life premiums were up 9% to $263 million and life underwriting margin was up 12% to $85 million. Net life sales were $55 million, up 3%. The average producing agent count for the first quarter was 6,780, up 1% from a year ago, but down 3% from the fourth quarter. The producing agent count at the end of the first quarter was 6,947. At Liberty National, life premiums were up 1% to $70 million, while life underwriting margin was down 12% to $16 million. Net life sales increased 4% to $11 million, and net health sales were $5 million, up 11% from the year-ago quarter. The sales increase was driven primarily by growth in agent count. The average producing agent count for the first quarter was 2,087, up 15% from a year ago, but down 1% compared to the fourth quarter. The producing agent count of Liberty National ended the quarter at 2,224. Our Direct Response operation at Globe Life, life premiums were up 1% to $212 million, and life underwriting margin increased 14% to $34 million. Net life sales were down 17% to $32 million. As we have discussed on previous calls, the sales decline is by design. We continue to refine and adjust our marketing programs in an effort to maximize the profitability of new sales. At Family Heritage, health premiums increased 8% to $66 million and health underwriting margin increased 41% to $16 million. Health net sales grew 1% to $13 million. The average producing agent count for the first quarter was 988, up 11% from a year ago and down 14% from the fourth quarter. The producing agent count at the end of the quarter was 1,026. At United American General Agency, health premiums increased 2% to $94 million. Net health sales were $14 million, up 24% compared to the year-ago quarter, due to increases on both the group and individual Medicare supplement units. To complete my discussion on the market operations, I will now provide some forward-looking information. Approximate life net sales trends for the full year 2018 are expected to be as follows: American Income, 5% to 9% growth; Liberty National, 9% to 13% growth; Direct Response, 6% to 10% decline. Approximate health net sales trends for the full year 2018 are expected to be as follows: Liberty National, 2% to 6% growth; Family Heritage, 5% to 9% growth; United American Individual Medicare supplement, 5% to 9% growth. I will now turn the call back to Gary.

I want to spend a few minutes discussing our investment operations; first, our excess investment income. Excess investment income, which we define as net investment income less required interest on net policy liabilities and debt was $62 million, a 4% increase over the year-ago quarter. On a per share basis, reflecting the impact of our share repurchase program, excess investment income was up 8%. For the full year, we expect excess investment income to grow by about 3%. However, on a per share basis, we should see an increase of about 6%. And so our investment portfolio, invested assets were $16 billion, including $15.3 billion of fixed maturities and amortized costs. Of the fixed maturities, $14.6 billion are investment grade, with an average rating of A- and below investment grade bonds were $688 million compared to $711 million a year ago. In the percentage of low investment grade bonds of fixed maturities is 4.5% compared to 4.9% a year-ago, with a portfolio leverage of 3.2 times, the percentage of below investment grade bonds to equity, excluding net unrealized gains on fixed maturities is 14%. Overall the total portfolio is rated BBB+, the same as the year-ago quarter. In addition, we have net unrealized gains in the fixed maturity portfolio of $1.4 billion, approximately $90 million higher than a year-ago. Regarding investment yield, in the first quarter we invested $359 million in investment-grade fixed maturities, primarily in industrials and tax immunities. We invested at an average yield of 4.46%, an average rating of A, and an average life of 23 years. For the entire portfolio, the first quarter yield was 5.58%, down 12 basis points from the 5.7% yield in the first quarter of 2017. As of March 31, the portfolio yield was approximately 5.57%. For 2018, the midpoint of our current guidance assumes an average new money yield of 4.75% for the full year. We would like to see higher interest rates going forward. Higher new money rates will have a positive impact on operating income by driving up excess investment income. We are not concerned about potential unrealized losses that are interest rate-driven, since we would not expect to realize them. We have the intent, and more importantly, the ability to hold our investments to maturity. However, if rates don't rise, a continued low interest rate environment will impact our income statement, but not the GAAP or statutory balance sheet, since we primarily sell noninterest-sensitive protection products accounted for under FAS 60. While we would benefit from higher interest rates, Torchmark would continue to earn substantial excess investment income in an extended low interest rate environment. Now, I will turn the call back to Frank.

Thanks, Gary. First, I want to spend a few minutes discussing our share repurchases and capital position. The parent ended the year with liquid assets of $48 million. In addition to these liquid assets, the parent will generate excess cash flow in 2018. The parent company's excess cash flow, as we define it, results primarily from the dividend received by the parent from its subsidiaries, less the interest paid on debt and the dividends paid to Torchmark shareholders. We expect excess cash flow in 2018, to be in the range of $325 million to $335 million. Thus, including the assets on hand at the beginning of the year, we currently expect to have around $375 million to $385 million of cash and liquid assets available to the parent during the year. In the first quarter, we spend $87 million to buy 1 million Torchmark shares at an average price of $86.32. So far in April, we have spent $18 million to purchase 220,000 shares. Thus, for the full year through today, we have spent $105 million of parent company cash to acquire more than 1.2 million shares at an average price of $85.40. These purchases were made from the parent company's excess cash flow. As noted on previous calls, we will use our cash as efficiently as possible. If market conditions are favorable, we expect that share repurchases will continue to be a primary use of those funds. We also expect to retain approximately $50 million of parent assets at the end of 2018, absent the need to utilize any of these funds to support our insurance company operations. Now, regarding capital levels at our insurance subsidiaries. Our goal is to maintain capital at levels necessary to support our current ratings. For the past several years, that level has been…

Thank you, Frank. Those are our comments. We will now open the call up for questions.

Thank you. [Operator Instructions] Our first question will come from Jimmy Bhullar from J.P. Morgan.

Hi, good morning. So first, I had a question on just your life sales, especially in Direct Response. I would have - and, obviously, you have been indicating that sales are going to be weak, because you're limiting marketing. But I would have thought that once you lapped through the difficult comps, then sales would begin to stabilize and that obviously hasn't happened. Are you still comfortable that you're going to start growing? I think you had mentioned before by 2018 or early 2019.

Jimmy, this is Larry, I think that by early 2019 - we do expect this to be the low point of the year in a year-over-year comparison basis, the declines to soften throughout 2018 and be flat or close to flat by the fourth quarter. Year-over-year declines are primarily due to the higher rates and stricter underwriting implemented throughout 2017. The last of these changes were implemented effectively at the beginning of the first quarter of 2018. We continue to evaluate the results of these changes, determine if any additional adjustments need to be made.

Okay. And then, any color on your health sales? They've been fairly strong. I think you had two double-digit growth quarters in the row. Is it something that you're doing on the product front or is it just the market conditions is what's really driving that and…?

I think market conditions are driving that. Our emphasis still remains on life sales, but we have a little stronger than expected health sales, particularly at Liberty National.

Okay. And then just lastly on stock options expense, that was actually fairly high this quarter. I think the $5 million, it's been - it wasn't even that for the whole year last year. What's your expectation for that? I think part of the reason for the increase is lower tax rate, so what's your expectation for that on a go-forward basis?

Yeah, Jimmy, I think it should be around that $5 million per quarter. We anticipate for the year it should be in the range of $19 million to $23 million. And it does have some volatility in it, just because it does changes as our stock price changes, and depending upon actual stock option exercises during the year that has an impact on the excess tax benefits that runs into that number. But I think it is in line with what our expectations are for the year.

Okay. Thank you.

Thank you. [Operator Instructions] Our next question comes from Erik Bass from ‎Autonomous Research.

Hi. Thank you. Just given the favorable margins you saw in Direct Response this quarter and the change, and your expectation for the year there as well as I think you revised the target for health underwriting income up a little bit. Why not increase the midpoint of guidance for the full year? Is this just conservatism or do you see any offsetting negatives versus your prior expectations?

Yeah. Hi, Erik. I think there are several different moving parts with respect to the guidance. We did increase our expectation with respect to Direct Response just a little bit. We actually did lower them a little bit with respect to Liberty National as well due to some of their higher claims in the first quarter. And then we are seeing just a little bit of an uptick on the stock option or stock compensation expense for the year as well. Just kind of net-net, at this point in time still being early in the year, we're leaving it the same.

Got it. Thank you. And you've talked previously about having debt capacity in the event of needing to rebuild your RBC ratio. And the debt to capital has come down as a result of tax reform. And so, what do you target for the leverage ratio longer term and then how much capacity does this give you?

Well, we do think by the end of 2018 that our debt/cap ratio will dip below 23%. That's definitely lower than what we had in quite a number of years. We do think that we have capacity to be able to stay within the guideline expressed by our rating agencies and to keep our existing ratings as of - by the end of the year that will actually be over $600 million. Now, so that amount of capacity. That wouldn't necessarily be the target that we'd want to go for. And we'll just have to see as the year plays out what our - how we might think about what our target ratio might be.

Thank you. And then just last quickly, do you have any preliminary estimate of the potential impact on your RBC ratio from the proposed changes to the C-1 charges for investments?

Now, we really don't at this point in time. It's just too early and we just haven't received enough guidance from the NAIC to have a good indication of what they think that those changes might actually be.

Okay. Thank you.

Thank you. Next question, we have Bob Glasspiegel from Janney Montgomery Scott.

Good morning, Torchmark. You were short of implying the lower margins in Liberty National as a surprise. I mean, it was a surprise going into the year. But we have had about as bad a flu season as you could have had. I actually was a bit reassured it wasn't worse. Am I looking at it the wrong way or…?

No, Bob. Actually, we expect it to be higher in the first quarter. It's a little bit higher than our expectation. But if you go back and look at the history of Liberty National, the first quarter claims are usually higher. For the last five years, we've had policy obligations percentage, that's in the 39% range we had this quarter. The real difference was last year, it was low. It was at 37%. We expected a higher first quarter and for it to lower as the year goes on. And we expect to be at a 37% ratio for the year. So it wasn't that much of a surprise, but it was a little bit higher than what we expected. But we - again, we expect it to level out through the rest of the year and then we'll - the policy obligation ratio for the full year will be around 37%, which is what it has in the last few years.

I may be beating a dead horse here, Gary, I apologize. But I'm just saying, going into the year, you did not expect the flu season to be the worst it's ever been. At the end of the quarter, when you realized the flu season was awful for the industry, it was still worse than you would have thought in light of a horrific flu season? I mean, I think we're going to see this from other companies as well. I mean, it's not a Liberty-National-specific issue. It was - first quarter, we had rotten weather and the flu was rampant, particularly in your regions. So, I mean, I don't think it's a bigger surprise, but it sounds like you're saying it was worse than you would have thought given how bad the flu season was or is it not what you're saying?

Well, no, we didn't see that big of impact from the flu season in terms of the cause of deaths in the first quarter. So we really - we didn't - going into the quarter, we weren't sure what we'd have from the flu standpoint. We did not see a big uptick in flu-related claims. But the cause of deaths were pretty much as they always are. It's just the fact that - with that in mind, the total was little bit higher than what we would've expected. But we really - we did not get harder by those - by flu.

Okay. I see there are trade publication stories that Nestlé has put Gerber Life up for the market. I don't know whether the stories are confirmed or not. But would you potentially have interest if it was available?

Yeah, Bob. We have seen those same announcements. I think Goldman had an announcement as well that they were going to put it up for sale. And we talked in the past that Gerber does fit the profile of the sort of the company that we would generally be interested in. It has protection products, certainly in the middle income market, and does have a control distribution. So I think at least at this point in time, we'd be interested. Best to our knowledge, no process has started at this point in time.

Okay. Good luck on that. Thank you.

Thank you. [Operator Instructions] Our next question comes from Alex Scott of Goldman Sachs.

Hi, good morning. First question was just on tech [ph] expenses. It looks like across some of your expenses were a little higher at the margin. And I guess like the overall like corporate admin expenses would have been higher. Just wondering what's sort of baked into your 2018 guidance for sort of a year-over-year headwind, if there is any from tax expense. And are we sort of at a peak levels and that would decline from here? Or should we just kind of think that, that all will continue to slowly pick up as you kind of integrate systems, et cetera?

Yeah, just - Alex, just to clarify, I understand on the admin expenses, but you said tax expenses, our non-deferred acquisition expenses? Is that what you meant or…?

Yeah, yeah.

Yeah, okay. And I think - yeah, we are seeing a little bit of an uptick on our non-deferred acquisition expenses, really reflecting to the large part two things, and this is really true with respect to our admin expense as well, both an uptick in our pension expenses as well as an uptick in our IT-related expenses. So we have been investing a fair amount on agency IT systems as well as analytics and security, and other modernization initiatives across the organization. And so we do have larger than normal increases, if you will, as some of those projects come onboard and the depreciation started to take hold.

And so, would you consider this to be more of like a peak year in terms of the level of those expenses and it would fade from here? Or is that something that will just remain for a while?

Yeah, I wouldn't anticipate that the level of - increases would continue going forward, and that we would expect them to be at about this level or - and they would - yeah, we would anticipate some at least slight growth over time as we continue to invest. But - and then on the pension expense, obviously, that is more reliant on how interest rates behave and the changes in those rates and the impact that that has on our overall pension expense.

Okay. Thanks for that. And second question, just on some of your health products, have you taken any pricing action or do you plan to take any pricing action, just related tax reform or any other factors?

No, not at this point in time. It is something that we will continue to look at. We continue to look especially on our health and in the Med-sup lines, from a competitive perspective. And we'll just continue to evaluate that as the year goes on.

Okay. Thanks very much.

Thank you. Our next question comes from Sam Hoffman of Lincoln Square.

Good morning. I just had a question on - to ask you if you could clarify how you determine your capital needs and free cash flow. Is it going to be based on RBC, and any changes that NAIC makes to the formula? Or is it going to be based on rating agency capital models and the guidance they give you on ratings?

Yeah, so I think with respect to our excess free cash flow, initially, the levels of that are all based upon the amount of dividends that we have available to be paid out of our insurance company less than the interest that we have on our debt and the dividends that we pay to our shareholders. So - and then as we think about, do we need to put - use some of that to support our capital level, we're - it's going to be based upon discussions with our regulators to make sure that as we look - as we do look at what the change in the factors are, what are those adequate amount or appropriate amounts of capital for us to maintain given our risk profile. Once we're satisfied with where the regulators are, we will continue to have those discussions with rating agency and then make those determinations with respect to what are the appropriate levels of capital to maintain or to reach desired levels of our rating. So it will all take into - it will take into account those discussions with the rating agencies as well as the regulators just based on what we all agree as a - together with respect to what appropriate level we would need to maintain.

So do you see all the - this, the regulators change the RBC formula, do you think the rating agencies will change their view in terms of the amount of capital, they'll require you to hold?

I really can't say at this point in time. It's too early to tell. Some of the rating agencies have their own model, so that they - it may not have much of an impact at all. Some of the other rating agencies do rely more on the NAIC RBC formula. And we haven't had any meaningful discussions with them at this point in time to really get a true understanding in our situation of how they want to think about it.

Okay. Thanks.

[Operator Instructions] Our next question comes from Ryan Krueger of KBW.

Hi, thanks. Good morning. I had a follow-up question on potential M&A. I guess, to the extent a transaction was available, can you discuss how much balance sheet capacity you would expect to have to be able to do a M&A transaction? And, I guess, if you'd be willing to either suspend share repurchase or issue equity to fund the deal if it was on the larger end?

Yeah, Ryan. With respect to total debt capacity, as indicated earlier that we probably have about $600 million to maintain with existing limits that are been set out by our rating agencies. It would be, if the right situation came around and we were - and we needed to use some of our excess cash flows to fund an acquisition, we would be willing to do so, as long as it made financial sense. So, obviously, as we modeled out any type of acquisition, we would simply be looking at what's the best way to finance that? Is it straight debt? Is it a combination of debt and use of our free cash flows or do we use all of our free cash flows? And have to work that all into the analysis to determine, just to make that it would make sense for our shareholders.

Ryan, it also makes the differences to which kind of company we're looking at. We said in the past that we're looking at companies that are in generally the middle income market with capital distribution, selling similar products. And those companies tend to have a strong cash flow. Although, Frank mentioned the $600 million of - yes, we could probably even borrow more than that if we can demonstrate that we can pay it back fairly quickly from the cash from the company we acquire. So I wouldn't say $600 million is the limit. I think we could probably go more than that depending on the type of company that we would purchase.

Got it. Thanks. And then, you had previously talked, I think about a potential reduction in the RBC ratio of 40 to 60 points if tax reform was incorporated. Have you been able to evaluate the potential impact based on the updated proposals from the NAIC that would kind of partially mitigate the impact?

We have not updated to give you those initial calculations at all at this point in time. I do understand that they're at least considering pullback on some of those factors and they may not actually be as severe as what some initial factors that they had issued. I have also seen where the Academy of Actuaries has at least recommended that they redo their models and come up with some new factors. So that's why it's really kind of up in the air at this point in time.

Got it. Okay. Thanks a lot.

Sir, at this time, I am showing no further questions in the queue.

All right. Thank you for joining us this morning. Those are our comments, and we'll talk to you again next quarter.

Thank you, ladies and gentlemen. This concludes today's teleconference. You may now disconnect.